Catherine J. Mackey - Jul 1, 2021 Form 4 Insider Report for Trillium Therapeutics Inc. (TRIL)

Role
Director
Signature
/s/ James Parsons, Attorney-in-Fact
Stock symbol
TRIL
Transactions as of
Jul 1, 2021
Transactions value $
$0
Form type
4
Date filed
7/2/2021, 04:35 PM
Previous filing
Jul 2, 2021
Next filing
Nov 19, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TRIL Stock Option (Right to Buy) Award $0 +67K $0.00 67K Jul 1, 2021 Common Shares 67K $9.70 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-third of the options vest on the one year anniversary of the grant date and the remaining options vest in equal quarterly installments over the following two years.